Boyer M - Search Results

1

Patient-reported outcomes following pembrolizumab or placebo plus pemetrexed and platinum in patients with previously untreated, metastatic, non-squamous non-small-cell lung cancer (KEYNOTE-189): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial.

Garassino MC, Gadgeel S, Esteban E, Felip E, Speranza G, Domine M, Hochmair MJ, Powell S, Cheng SY, Bischoff HG, Peled N, Reck M, Hui R, Garon EB, Boyer M, Wei Z, Burke T, Pietanza MC, Rodríguez-Abreu D. Garassino MC, et al. Among authors: boyer m. Lancet Oncol. 2020 Mar;21(3):387-397. doi: 10.1016/S1470-2045(19)30801-0. Epub 2020 Feb 6. Lancet Oncol. 2020. PMID: 32035514 Clinical Trial.

2

Recent advances in managing non-small-cell lung cancer: 4. Chemotherapy of metastatic cancer.

Clarke SJ, Boyer MJ. Clarke SJ, et al. Among authors: boyer mj. Med J Aust. 1997 Jun 2;166(S1):S14-6. Med J Aust. 1997. PMID: 9201199

3

Phase I study of paclitaxel and oral etoposide in previously untreated non-small-cell and extensive small-cell lung cancer.

Boyer MJ, Zalcberg J, Olver IN, Millward MJ, Richardson G, McKeage MJ. Boyer MJ, et al. Ann Oncol. 1997 May;8(5):485-9. doi: 10.1023/a:1008291606695. Ann Oncol. 1997. PMID: 9233529 Free article. Clinical Trial.

4

Non-surgical therapy for patients with advanced non-small cell lung cancer.

Clarke SJ, Boyer MJ. Clarke SJ, et al. Among authors: boyer mj. Respirology. 1998 Sep;3(3):175-82. doi: 10.1111/j.1440-1843.1998.tb00117.x. Respirology. 1998. PMID: 9767616 Review.

5

Phase II study of paclitaxel and oral etoposide in patients with locally advanced or metastatic non-small cell lung cancer.

Boyer MJ, Mitchell P, Goldstein D, Millward MJ, Olver IN, Clarke SJ, Richardson G, Davis I. Boyer MJ, et al. Lung Cancer. 2001 Apr;32(1):89-94. doi: 10.1016/s0169-5002(00)00207-5. Lung Cancer. 2001. PMID: 11282433 Clinical Trial.

6

Phase II trial of pemetrexed disodium (ALIMTA, LY231514) in chemotherapy-naïve patients with advanced non-small-cell lung cancer.

Clarke SJ, Abratt R, Goedhals L, Boyer MJ, Millward MJ, Ackland SP. Clarke SJ, et al. Among authors: boyer mj. Ann Oncol. 2002 May;13(5):737-41. doi: 10.1093/annonc/mdf115. Ann Oncol. 2002. PMID: 12075742 Free article. Clinical Trial.

7

Pemetrexed: single-agent and combination phase I study overview.

Boyer MJ, Rivory LP, Clarke SJ. Boyer MJ, et al. Semin Oncol. 2002 Dec;29(6 Suppl 18):18-23. doi: 10.1053/sonc.2002.37464. Semin Oncol. 2002. PMID: 12571806 Review.

8

Docetaxel and carboplatin is an active regimen in advanced non-small-cell lung cancer: a phase II study in Caucasian and Asian patients.

Millward MJ, Boyer MJ, Lehnert M, Clarke S, Rischin D, Goh BC, Wong J, McNeil E, Bishop JF. Millward MJ, et al. Among authors: boyer mj. Ann Oncol. 2003 Mar;14(3):449-54. doi: 10.1093/annonc/mdg118. Ann Oncol. 2003. PMID: 12598352 Free article. Clinical Trial.

9

Randomized controlled trial of the role of positron emission tomography in the management of stage I and II non-small-cell lung cancer.

Viney RC, Boyer MJ, King MT, Kenny PM, Pollicino CA, McLean JM, McCaughan BC, Fulham MJ. Viney RC, et al. Among authors: boyer mj. J Clin Oncol. 2004 Jun 15;22(12):2357-62. doi: 10.1200/JCO.2004.04.126. J Clin Oncol. 2004. PMID: 15197196 Clinical Trial.

10

A phase I/II study of pemetrexed and vinorelbine in patients with non-small cell lung cancer.

Clarke SJ, Boyer MJ, Millward M, Underhill C, Moylan E, Yip D, White S, Childs A, Beale P, Latz J, Suri A, Iglesias JL. Clarke SJ, et al. Among authors: boyer mj. Lung Cancer. 2005 Sep;49(3):401-12. doi: 10.1016/j.lungcan.2005.04.003. Lung Cancer. 2005. PMID: 15923057 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

927 results

Search Page

Filters